CWA
EDIT icon

Clearview Wealth Advisors’s Editas Medicine EDIT Stock Holding History

Clearview Wealth Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10
Closed -$82 – 259
2023
Q2 		$82 Hold
10
– – ﹤0.01% 676
2023
Q1 		$73 Hold
10
– – ﹤0.01% 662
2022
Q4 		$89 Hold
10
– – ﹤0.01% 610
2022
Q3 		$0 Hold
10
– – ﹤0.01% 594
2022
Q2 		$0 Hold
10
– – ﹤0.01% 602
2022
Q1 		$0 Hold
10
– – ﹤0.01% 638
2021
Q4 		$1K Hold
10
– – ﹤0.01% 633
2021
Q3 		$0 Hold
10
– – ﹤0.01% 667
2021
Q2 		$1K Hold
10
– – ﹤0.01% 611
2021
Q1 		$0 Hold
10
– – ﹤0.01% 622
2020
Q4 		$1K Buy
+10
New +$411 ﹤0.01% 535

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clearview Wealth Advisors's EDIT Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 10 shares — an estimated $82 sold.

Clearview Wealth Advisors first reported a position in EDIT in Q4 2020 and held it in 11 quarters. The position peaked at $1K in Q4 2021. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

  • Clearview Wealth Advisors reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
  • Clearview Wealth Advisors sold 10 Editas Medicine shares in Q3 2023, an estimated $82.
  • Clearview Wealth Advisors first reported a position in Editas Medicine in Q4 2020 and held it in 11 quarters.
  • Clearview Wealth Advisors's Editas Medicine position peaked at $1K in Q4 2021.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.